Companies / Lyell Immunopharma, Inc. / Transactions
Back to Lyell Immunopharma, Inc.

Lyell Immunopharma, Inc.

All insider transactions

16 transactions

Date ↓MoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
May 11, 2026Sell
ⓘ
Common StockSeely Lynn
CEO
-388$18.91$7.3K73,878low
Mar 6, 2026BuyCommon StockARCH Venture Partners IX, LLC
10% owner
+488,090$25.61$12.50M1,426,528high
Mar 6, 2026BuyCommon StockARCH Venture Fund XIII, L.P.
10% owner
+488,090$25.61$12.50M1,426,528high
Feb 11, 2026SellCommon StockLee Gary K.
Executive
-1,671$23.39$39.1K16,938low
Feb 11, 2026SellCommon StockHill Stephen J.
Executive
-1,236$23.39$28.9K17,795low
Feb 11, 2026SellCommon StockSeely Lynn
CEO
-7,455$23.39$174.4K74,266medium
Feb 10, 2026SellCommon StockBulis Veronica Sanchez
Executive
-254$23.12$5.9K15,637low
Feb 10, 2026Other
Grant / award
Common StockBulis Veronica Sanchez
Executive
+8,750$0.00$015,891low
Feb 10, 2026SellCommon StockLee Gary K.
Executive
-147$23.12$3.4K18,609low
Feb 10, 2026SellCommon StockHill Stephen J.
Executive
-109$23.12$2.5K19,031low
Feb 10, 2026SellCommon StockSeely Lynn
CEO
-438$23.12$10.1K81,721low
Feb 9, 2026Other
Grant / award
Common StockLee Gary K.
Executive
+4,000$0.00$018,756low
Feb 9, 2026Other
Grant / award
Common StockHill Stephen J.
Executive
+4,000$0.00$019,140low
Feb 9, 2026Other
Grant / award
Common StockSeely Lynn
CEO
+20,000$0.00$082,159low
Dec 30, 2025SellCommon StockBulis Veronica Sanchez
Executive
-936$32.32$30.3K7,141low
Dec 24, 2025SellCommon StockBulis Veronica Sanchez
Executive
-1,136$38.67$43.9K8,077low
← PrevPage 1 of 1Next →